Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors

Patient Satisfaction With Placement of Implantable Venous Access Devices

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01098643

Enrollment

Registered

2010-04-05

Start date

2009-10-31

Completion date

2011-09-30

Last updated

2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Keywords

unspecified adult solid tumor, protocol specific

Brief summary

RATIONALE: Gathering information about patients with solid tumors who have implantable venous access devices may help doctors learn more about patient satisfaction. PURPOSE: This phase I trial is studying satisfaction with placement of implantable venous access devices in patients with solid tumors.

Detailed description

OBJECTIVES: * To determine patient satisfaction with subcutaneous venous-access device placement in oncology patients. OUTLINE: Patients complete a computer-based survey while in the treatment area of the Vanderbilt Oncology Clinic. Basic demographic information and basic information regarding the placement of the device and complications are collected from the patient's medical record.

Interventions

OTHERcomputer-assisted intervention

OTHERmedical chart review

OTHERquestionnaire administration

OTHERsurvey administration

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Eligibility

Sex/Gender

ALL

Age

18 Years to 120 Years

Healthy volunteers

Inclusion criteria

DISEASE CHARACTERISTICS: * Diagnosis of a solid tumor malignancy * No hematological malignancy * Patient at the Vanderbilt Oncology Clinic * Has undergone placement of a subcutaneous, single-lumen venous-access device within the past 6 months * No patients who have had ≥ 2 venous-access devices placed by ≥ 1 department PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics * Not currently undergoing preparation for or process of stem cell transplantation

Design outcomes

Primary

Measure	Time frame
Overall satisfaction with port placement	n/a - study closed

Secondary

Measure	Time frame
Frequency of complications	—
Frequency of port failure	—
Need for removal of device	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026